100% Brand New Original Inverter PLC IS215VCMIH2C

Description

GE's 2021 outlook reflects a reduction in cash and profit from businesses that were disposed in 2020 (primarily BioPharma) as well as continued reduction of Baker Hughes shareholder dividends in line with the orderly sale of GE's remaining stake. In the first quarter of 2020, BioPharma generated nearly $300 million* in cash and $400 million in profit, and GE received more than $250 million in Baker Hughes dividends in 2020.

This outlook also assumes Aviation revenue being flat to up year-over-year, which is dependent on the Commercial Aviation market recovery accelerating in the second half of 2021 as well as the timing of aircraft deliveries. GE expects to improve operational performance in Power and Renewable Energy, with continued strength in Healthcare and better Capital earnings compared to 2020. GE also expects to achieve a GE Industrial net debt*/EBITDA* ratio of less than 2.5x over time and GE Capital remains committed to maintaining a debt-to-equity ratio of less than 4x. GE will hold an Investor Update on Wednesday, March 10, 2021, with additional details on its 2021 outlook, including by segment.

GE Fanuc In Stock

You May Like